Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up

2024; Springer Science+Business Media; Volume: 52; Issue: 3 Linguagem: Inglês

10.1007/s15010-023-02171-z

ISSN

1439-0973

Autores

Julian Triebelhorn, Jochen Schneider, Christoph D. Spinner, Roman Iakoubov, Florian Voit, Laura Wagner, Johanna Erber, Kathrin Rothe, Achim Berthele, Verena Pernpeintner, Elias Strauss, Lutz Renders, Anja Willmann, M. Minić, Emanuel Vogel, Catharina Christa, Dieter Hoffmann, Ulrike Protzer, Samuel Jeske,

Tópico(s)

Heparin-Induced Thrombocytopenia and Thrombosis

Resumo

This study assessed the clinical and immunological outcomes of SARS-CoV-2-infected patients with risk factors for severe disease depending on their immunological status.

Referência(s)